Raul Labrador Thinking About a Run for No. 2 House GOP Job

The conservative considers challenging Kevin McCarthy for majority leader, a source says.

Rep. Raul Labrador (R-ID), speaks at the Conservative Political Action conference (CPAC), on February 10, 2011 in Washington, DC. The CPAC annual gathering is a project of the American Conservative Union. 
National Journal
Tim Alberta
Add to Briefcase
Tim Alberta
June 12, 2014, 3:49 p.m.

Raul Lab­rador is quietly con­sid­er­ing a cam­paign for House ma­jor­ity lead­er, ac­cord­ing to a source fa­mil­i­ar with the con­gress­man’s think­ing, po­ten­tially set­ting up a head-to-head con­test with Ma­jor­ity Whip Kev­in Mc­Carthy to re­place Eric Can­tor.

“He’s get­ting a lot of en­cour­age­ment from oth­er mem­bers,” the source said.

Lab­rador was ap­proached by sev­er­al in­flu­en­tial con­ser­vat­ive mem­bers Thursday morn­ing after Rep. Jeb Hensarling an­nounced he would not chal­lenge Mc­Carthy for the No. 2 spot in lead­er­ship.

While Lab­rador en­joys strong sup­port among the most con­ser­vat­ive mem­bers of the House GOP, it’s un­clear wheth­er he would have the abil­ity — with the spe­cial elec­tion less than a week away — to build a broad­er co­ali­tion cap­able of giv­ing Mc­Carthy a com­pet­it­ive race.

As Lab­rador con­tem­plated their en­cour­age­ment to enter the race, an­oth­er Re­pub­lic­an, Rep. Pete Ses­sions, dropped his bid.

Lab­rador is now care­fully con­sid­er­ing wheth­er he wants to enter the fray — and wheth­er he could pos­sibly win.

An out­spoken sopho­more law­maker from Idaho, he is one of the most pop­u­lar tea-party-al­lied mem­bers of the GOP’s right flank.

Lab­rador has oc­ca­sion­ally rubbed some Re­pub­lic­ans the wrong way with his vo­cal cri­ti­cism of the cur­rent lead­er­ship team. He has fre­quently at­tacked that team for be­ing too pass­ive and is one of 12 mem­bers who re­fused to sup­port Speak­er John Boehner’s reelec­tion. He has con­sist­ently said the lead­er­ship team is not rep­res­ent­at­ive of the con­fer­ence be­cause it does not in­clude a red-state Re­pub­lic­an.

Lab­rador’s name has oc­ca­sion­ally been men­tioned as a dark-horse can­did­ate for a lead­er­ship po­s­i­tion. In fact, earli­er this year, Lab­rador joked in an in­ter­view with Na­tion­al Journ­al that he might “do something crazy” like run for speak­er of the House.

It’s un­clear what his timetable is for mak­ing a de­cision. Many law­makers have already left Wash­ing­ton and will not re­turn un­til Monday.

This story was up­dated with the news that Rep. Ses­sions had dropped his bid for ma­jor­ity lead­er.

What We're Following See More »
HEALTH IN QUESTION
Sen. Cochran Back to Washington Tuesday
5 hours ago
THE LATEST
THIRD VERSION OF THE BAN
Federal Judge Temporarily Stops Trump’s Travel Ban
6 hours ago
THE LATEST

"A federal district court in Hawaii has temporarily blocked the third iteration of President Trump's travel ban. Judge Derrick Watson said the new targeted restrictions on travel from eight countries Trump issued on Sept. 24 suffers the same problems as the previous order."

Source:
FORMER ELI LILLY EXEC
Trump Leaning Towards Alex Azar for HHS
6 hours ago
THE DETAILS

"President Donald Trump is leaning toward nominating Alex Azar, a former pharmaceutical industry executive and George W. Bush administration official, to serve as Health and Human Services secretary, according to two White House officials...Azar is a veteran of HHS. He served as the department’s general counsel and deputy secretary during the Bush administration." He led Eli Lilly's U.S. operations from 2012-17.

Source:
ENOUGH SUPPORT TO PASS?
Senators Reach Bipartisan ACA Deal
7 hours ago
THE LATEST

"Sen. Lamar Alexander says he and Sen. Patty Murray have reached a deal to fund the Affordable Care Act's cost-sharing subsidies in exchange for giving states more regulatory flexibility with the law." Axios is watching to see if the deal will gather support.

Source:
INDEX UP MORE THAN 20% SINCE ELECTION
Dow Jones Hits 23,000 Threshold
10 hours ago
THE DETAILS
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login